Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $2.66 Million - $3.03 Million
-27,900 Reduced 91.78%
2,500 $241,000
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $978,062 - $1.08 Million
10,600 Added 53.54%
30,400 $3.07 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $1.49 Million - $1.65 Million
15,700 Added 382.93%
19,800 $2.02 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $379,332 - $430,131
4,100 New
4,100 $413,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $354,288 - $412,500
4,400 Added 169.23%
7,000 $592,000
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $208,286 - $235,612
2,600 New
2,600 $228,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $334,000 - $393,880
-4,000 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $132,719 - $160,531
-1,700 Reduced 29.82%
4,000 $378,000
Q3 2020

Nov 16, 2020

SELL
$82.14 - $91.0 $4.04 Million - $4.48 Million
-49,200 Reduced 89.62%
5,700 $496,000
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $1.94 Million - $2.19 Million
23,000 Added 72.1%
54,900 $5.2 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $1.09 Million - $1.34 Million
14,400 Added 82.29%
31,900 $2.91 Million
Q1 2019

May 15, 2019

SELL
$75.32 - $86.15 $1.39 Million - $1.59 Million
-18,400 Reduced 51.25%
17,500 $1.68 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $2.98 Million - $3.31 Million
-40,400 Reduced 52.95%
35,900 $3.08 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $468,580 - $542,010
7,000 Added 10.1%
76,300 $6.57 Million
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $9.97 Million - $11.3 Million
-153,600 Reduced 68.91%
69,300 $5.24 Million
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $15.4 Million - $18.4 Million
218,500 Added 4965.91%
222,900 $18 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $318,252 - $341,616
4,400
4,400 $369,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.